Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women (vol 8, pg 297, 1999)

被引：0
|
作者：
Gealy
机构：
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2001年 / 10卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1309 / 1309
页数：1
相关论文
共 50 条
  • [31] Promoter methylation of RASSFIA and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers
    Liu, Yang
    Gao, Weimin
    Siegfried, Jill M.
    Weissfeld, Joel L.
    Luketich, James D.
    Keohavong, Phouthone
    BMC CANCER, 2007, 7 (1)
  • [32] P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma
    Jassem, J
    Jassem, E
    Jakóbkiewicz-Banecka, J
    Rzyman, W
    Badzio, A
    Dziadziuszko, R
    Kobierska-Gulida, G
    Szymanowska, A
    Skrzypski, M
    Zylicz, M
    CANCER, 2004, 100 (09) : 1951 - 1960
  • [33] Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma:: comparison with K-ras mutation
    Wang, Y
    Yamaguchi, Y
    Watanabe, H
    Ohtsubo, K
    Wakabayashi, T
    Sawabu, N
    JOURNAL OF GASTROENTEROLOGY, 2002, 37 (10) : 831 - 839
  • [34] Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K-ras mutation
    Ying Wang
    Yasushi Yamaguchi
    Hiroyuki Watanabe
    Koushiro Ohtsubo
    Tokio Wakabayashi
    Norio Sawabu
    Journal of Gastroenterology, 2002, 37 : 831 - 839
  • [35] K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers
    Itoi, T
    Takei, K
    Shinohara, Y
    Takeda, K
    Nakamura, K
    Horibe, T
    Sanada, A
    Ohno, H
    Matsubayashi, H
    Saito, T
    Watanabe, H
    PATHOLOGY INTERNATIONAL, 1999, 49 (01) : 30 - 37
  • [36] K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients
    Shivapurkar, N
    Huang, L
    Ruggeri, B
    Swalsky, PA
    Bakker, A
    Finkelstein, S
    Frost, A
    Silverberg, S
    CANCER LETTERS, 1997, 115 (01) : 39 - 46
  • [37] Intratumor heterogeneity of k-ras and p53 mutations among human colorectal adenomas containing early cancer (vol 21, pg 49, 2000)
    Giaretti, W
    Rapallo, A
    Sciutto, A
    Macciocu, B
    Geido, E
    Hermsen, MAJA
    Postma, C
    Baak, JPA
    Williams, RA
    Meijer, GA
    ANALYTICAL CELLULAR PATHOLOGY, 2001, 22 (03): : 181 - 181
  • [38] Evaluation of PCNA, p53, K-ras and LOH in endocrine pancreas tumors (vol 47, pg 875, 2000)
    Sato, T
    Konishi, K
    Kimura, H
    Maeda, K
    Yabushita, K
    Masahiko, T
    Miwa, A
    HEPATO-GASTROENTEROLOGY, 2000, 47 (35) : VIII - VIII
  • [39] K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer
    Y Fukuyama
    T Mitsudomi
    K Sugio
    T Ishida
    K Akazawa
    K Sugimachi
    British Journal of Cancer, 1997, 75 : 1125 - 1130
  • [40] TYPE OF P53 MUTATION INFLUENCES ONCOGENIC POTENTIAL AND SPECTRUM OF ASSOCIATED K-RAS MUTATIONS IN LUNG SPECIFIC TRANSGENIC MICE
    Duan, Wenrui
    Gao, Li
    Kalvala, Arjun
    Brooks, Christopher Christopher
    Barnwell, Brittany
    Mo, Xiaokui
    Ding, Haiming
    Shilo, Konstantin
    Otterson, Gregory
    Villalona-Calero, Miguel
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S738 - S739
12345